Certara Investor Day Presentation Deck slide image

Certara Investor Day Presentation Deck

Addressing safety issues consistently and earlier Secondary Intelligence CERTARA ToxStudio®: Secondary Intelligence™ (V1.0) Projects Project Compounds Receptors Compound Assessment Thresholds You are here: Projects / Compound Assessment Compound assessment for Compound A Compound Assessment Compound Comparison Focus Compound Receptor B2-adrenoceptor ENT 1 adenosine ACHE PDE 40 B1-adrenoceptor PDE 3A C1A-adrenoceptor 2A-adrenoceptor H 2 histamine SERT serotonin Compound A Compound B Compound C Compound D Compound E Compound F Compound G v1 Compound H Compound I Compound J ● ● ● Toxicology and safety pharmacology impact organ-specific drug exposure Biosimulation tools can simulate and predict safety issues More efficient and consistent than traditional method Reduction in animal use Relevant for adjacent industries 43 CERTARA
View entire presentation